Health care industry
Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
The exterior view of the entrance to Merck headquarters in Rahway, New Jersey, on Feb. 5, 2024. Spencer Platt | Getty Images Merck on Thursday reported third-quarter revenue and adjusted earnings that topped expectations as the company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business. But […]
Read More
CDC says 90 people affected in E. coli outbreak linked to McDonald’s Quarter Pounders
A Quarter Pounder with cheese, fries and a drink arranged at a McDonald’s restaurant in El Sobrante, California, on Oct. 23, 2024. David Paul Morris | Bloomberg | Getty Images Ninety people in 13 states have been infected in a deadly E. coli outbreak linked to McDonald’s Quarter Pounders, the Centers for Disease Control and […]
Read More
Novo Nordisk’s Ozempic and Wegovy now available in the U.S. after shortages, FDA says
Packages containing syringes of the medications Wegovy, Ozempic and Mounjaro at a shop in Mitte, Germany, July 11, 2024. Picture Alliance | Picture Alliance | Getty Images All doses of Novo Nordisk‘s highly popular weight loss injection Wegovy and diabetes drug Ozempic are now available in the U.S., according to an update on the U.S. […]
Read More
Fired Disney employee allegedly hacked menu system to falsely claim certain foods did not contain peanuts, complaint says
The “Partners” statue of Walt Disney and Mickey Mouse, at Cinderella Castle at the Magic Kingdom, at Walt Disney World, in Lake Buena Vista, Florida, photographed Saturday, June 3, 2023. Joe Burbank | Tribune News Service | Getty Images A disgruntled former Disney employee is being accused of hacking into menu-creating software used by the […]
Read More
Eli Lilly’s Zepbound and Mounjaro are no longer in shortage. Here’s where their sales still fell short
Eli Lilly’s blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro posted weaker-than-expected sales for the third quarter, even as supply of both medicines have largely recovered from widespread shortages in the U.S. The reason, according to the company, is not an issue of demand or supply. Eli Lilly instead blamed disappointing sales on drug […]
Read More
We’re hiking our GEHC price target, looking beyond a mixed quarter to next year’s catalysts
GE Healthcare reported a mixed quarter before Wednesday’s opening bell. While revenue slightly missed, an earnings beat along with a number of other positives pushed the stock higher. Revenue rose just under 1% year over year to $4.86 billion in the third quarter, just short the $4.87 billion expected, according to analyst estimates compiled by […]
Read More
Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance
Lilly Biotechnology Center is shown in San Diego, California, U.S. March 1, 2023. Mike Blake | Reuters Eli Lilly on Wednesday fell short of profit and revenue expectations for the third quarter, weighed down by disappointing sales of its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro, and slashed its full-year adjusted profit guidance. […]
Read More
Biogen tops estimates, raises profit guidance as Alzheimer’s drug Leqembi gains traction
A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado Ruvic | Reuters Biogen on Wednesday reported third-quarter revenue and adjusted earnings that topped expectations while raising its full-year profit guidance, as sales of its breakthrough Alzheimer’s drug, Leqembi, and other new products gain traction. […]
Read More
23andMe appoints three new board members following abrupt resignations
ATHERTON, CALIFORNIA – MARCH 15: Anne Wojcicki attends the WSJ. Magazine Style & Tech Dinner on March 15, 2023 in Atherton, California. (Photo by Kelly Sullivan/Getty Images for WSJ.) Kelly Sullivan | Getty Images Entertainment | Getty Images 23andMe appointed three new independent directors to its board, the company announced Tuesday, one month after all […]
Read More
McDonald’s executives say E. coli outbreak is ‘behind us’
McDonald’s Chris Kempczinski speaks about fresh beef expansion at a McDonald’s event in Oak Brook, Illinois. Richa Naidu | Reuters A week after health authorities publicly linked a deadly E. coli outbreak to McDonald’s Quarter Pounder burgers, the company’s CEO, Chris Kempczinski, told investors that the situation is now behind them. “How we’ve handled the […]
Read More